BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/13/2024 7:07:39 AM | Browse: 378 | Download: 879
Publication Name World Journal of Clinical Cases
Manuscript ID 96769
Country Cyprus
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https: //creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Editorial
Article Title Hidden army within: Harnessing the microbiome to improve cancer treatment outcomes
Manuscript Source Invited Manuscript
All Author List Ippokratis Messaritakis, Georgios Vougiouklakis, Asimina Koulouridi, Aris P Agouridis and Nikolaos Spernovasilis
ORCID
Author(s) ORCID Number
Aris P Agouridis http://orcid.org/0000-0002-9749-5075
Nikolaos Spernovasilis http://orcid.org/0000-0002-6981-8535
Funding Agency and Grant Number
Corresponding Author Nikolaos Spernovasilis, BSc, MD, MSc, PhD, Director, Director, Department of Infectious Diseases, German Oncology Center, Nikis 1, Limassol 4108, Cyprus. nikspe@hotmail.com
Key Words Gut microbiome; Cancer treatment; Immunotherapy; Microbiome-based interventions; Dysbiosis; Precision oncology
Core Tip Understanding the intricate relationship between the gut microbiome and cancer treatment outcomes is pivotal in modern oncology. Dysbiosis, an imbalance in gut microbial communities, significantly influences tumor initiation, progression, and response to therapy. Harnessing the microbiome's potential offers novel avenues for personalized cancer care, including optimizing treatment strategies and enhancing immunotherapy efficacy. Multidisciplinary collaboration, standardized methodologies for microbiome profiling, and the development of microbial biomarkers are essential for translating microbiome research into clinical practice. Ethical considerations and regulatory oversight are paramount in ensuring equitable access to emerging microbiome-based interventions while promoting transparency and education among healthcare professionals and the public.
Publish Date 2024-08-13 07:07
Citation

Messaritakis I, Vougiouklakis G, Koulouridi A, Agouridis AP, Spernovasilis N. Hidden army within: Harnessing the microbiome to improve cancer treatment outcomes. World J Clin Cases 2024; 12(28): 6159-6164

URL https://www.wjgnet.com/2307-8960/full/v12/i28/6159.htm
DOI https://dx.doi.org/10.12998/wjcc.v12.i28.6159
Full Article (PDF) WJCC-12-6159-with-cover.pdf